Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate

• Published in: The Lancet (British edition) Vol. 340; no. 8831; pp. 1326 - 1329
• Main Authors: van Acker, B.A.C., Koopman, M.G., Arisz, L., Koomen, G.C.M., de Waart, D.R.
• Format: Journal Article
• Language: English
• Published: London Elsevier Ltd 28.11.1992; Lancet; Elsevier Limited
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Biological and medical sciences; Cimetidine; Cimetidine - administration & dosage; Cimetidine - pharmacology; Creatinine; Creatinine - blood; Creatinine - pharmacokinetics; Creatinine - urine; Disease; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Glomerular filtration rate; Glomerular Filtration Rate - drug effects; Humans; Inulin; Inulin - blood; Inulin - urine; Investigative techniques of renal and urinary tract function; Investigative techniques, diagnostic techniques (general aspects); Kidney diseases; Kidney Diseases - diagnosis; Kidney Diseases - metabolism; Kidney Diseases - physiopathology; Kidney Tubules - drug effects; Kidney Tubules - metabolism; Kidneys; Medical research; Medical sciences; Metabolic Clearance Rate; Middle Aged; Priming; Reproducibility of Results; Secretion; Unity; Creatinine; Human; Urinary system disease; Glomerular filtration; Renal function; Exploration; Renal disease; Clearance; Antihistaminic; Chemotherapy; Treatment; Antisecretory agent; Technique
• ISSN: 0140-6736; 1474-547X
• DOI: 10.1016/0140-6736(92)92502-7

Creatinine clearance inaccurately estimates true glomerular filtration rate (GFR) because of tubular secretion of creatinine. We studied the ability of oral cimetidine, a blocker of tubular creatinine secretion, to improve the accuracy of measuring creatinine clearance. Clearances of inulin and endogenous creatinine were simultaneously measured in 16 patients with renal disease before administration of cimetidine and during 8 successive 3 h clearance periods with cimetidine 400 mg as priming dose followed by 200 mg every 3 h. At baseline, creatinine relative to inulin clearance (ClC/ClI) ranged from 1·14 to 2·27. With cimetidine, ClC/ClI approached unity in 8 patients (mean 1·02 [SD 0·03]), but considerably exceeded unity in 8 others (1·33 [0·14]). Plasma cimetidine/ creatinine ratio was smaller in this second group, due to significantly higher renal clearance of cimetidine (333 [136] vs 165 [89] ml/min, p=0·01). In a further study, cimetidine dose and, consequently plasma cimetidine concentration, was increased in 6 additional patients who had incomplete inhibition previously. This increased dose completely inhibited tubular creatinine secretion in the third until the sixth hour, so that creatinine clearance equalled GFR. Provided an adequate dose of cimetidine is given, 24 h creatinine clearance during administration of drug measures G FR accurately in patients with renal disease. However, because of the maximum daily dose of cimetidine that is advised, short clearance times (3 h) are recommended.